Related Experiment Video
Updated: Nov 24, 2025

Platelet-Rich Plasma Lysate for Treatment of Eye Surface Diseases
Published on: August 2, 2022
Platelet activating factor in the eye: Physiological roles, diseases and future perspectives
Barbara Dalmaso1, Ildefonso Alves da Silva-Junior2, Lucianne Fragel-Madeira3
1Department of Cell and Developmental Biology, Biomedical Sciences Institute, University of Sao Paulo, São Paulo, Brazil.
Platelet Activating Factor (PAF) is crucial for eye biology, regulating inflammation and cell signaling. PAF receptor (PAFR) antagonists show promise in treating ocular diseases like AMD and diabetic retinopathy.
Area of Science:
- Ophthalmology
- Neuroscience
- Cell Biology
Background:
- Platelet Activating Factor (PAF) is a phospholipid mediator involved in inflammation and cellular functions like proliferation, adhesion, and apoptosis.
- PAF and its receptor (PAFR) play critical roles in nervous system tissues, particularly the retina, influencing vision and optical homeostasis.
- PAF regulates physiological functions in the visual system, including eye development, inflammation, wound healing, and synaptic activity.
Purpose of the Study:
- To review the current understanding and future perspectives of Platelet Activating Factor (PAF) signaling in eye biology and ophthalmology.
- To highlight the role of PAF and PAFR in various physiological and pathological processes within the visual system.
- To discuss the therapeutic potential of targeting PAFR in ocular disorders.
Main Methods:
- Literature review of studies on PAF and PAFR in ocular tissues and diseases.
- Analysis of research on the physiological and pathological functions of PAF in the visual system.
- Examination of data from studies using PAFR antagonists in preclinical models and clinical contexts.
Main Results:
- PAF and PAFR are implicated in numerous ocular functions and disorders, including Age-related Macular Degeneration (AMD), Diabetic Retinopathy (DR), and Choroidal Neovascularization (CNV).
- PAFR antagonists have demonstrated efficacy in inhibiting neovascularization, treating retinopathies, reducing inflammation, and preventing retinal cell death.
- PAF signaling is integral to visual system homeostasis and disease pathogenesis.
Conclusions:
- PAF and PAFR signaling pathways are significant targets for therapeutic intervention in a range of ophthalmic conditions.
- Further research into PAFR-targeted therapies holds promise for novel treatments in ophthalmology.
- Understanding PAF's role is essential for advancing treatments for blinding eye diseases.
More Related Videos
08:10An Ex Vivo Tissue Culture Model for Fibrovascular Complications in Proliferative Diabetic Retinopathy
Published on: January 25, 2019
10:24Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report
Published on: February 12, 2018
Related Concept Videos
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Clot Retraction and Fibrinolysis